PARP1 and lip and oral cavity carcinoma: In addition, PARP has been discovered to be overexpressed in several types of cancers, such as breast, ovarian and oral cancers, making inhibition of PARP activity a promising strategy for cancer therapy by disrupting PARP functions, thereby impairing the DDR pathways of cancer cells.